The Evolving Evidence-Based And Guideline-Supported Role For Nanoliposomal Topoisomerase Inhibitors In Metastatic Pancreatic Adenocarcinoma

The Evolving Evidence-Based And Guideline-Supported Role For Nanoliposomal Topoisomerase Inhibitors In Metastatic Pancreatic Adenocarcinoma


Published

December 11, 2017

Created by

CMEducation Resources symposium